Literature DB >> 3761307

Preparation and antitumor activity of 7-substituted 1,2-aziridinomitosenes.

B S Iyengar, W A Remers, W T Bradner.   

Abstract

7-Methoxy-1,2-aziridinomitosenes were prepared from mitomycin A and its N-methyl homologue by catalytic reduction followed by air oxidation. Treatment of these products with amines, including ammonia, ethylenimine, 2-methylethylenimine, propargylamine, and furfurylamine gave the corresponding 7-(substituted amino) derivatives. Screening of these compounds against P-388 leukemia in mice revealed some good activities. The more easily reduced compounds gave prolongation of life span comparable to that of mitomycin C, but their optimal doses were higher. Among these compounds, a methyl group on the aziridine nitrogen increased potency. The 7-amino derivatives, which were difficult to reduce to hydroquinones, were essentially inactive. The aziridinomitosenes were subjected to a Hansch-type analysis, but no statistically significant correlation was found.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3761307     DOI: 10.1021/jm00160a012

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Formal synthesis of 7-methoxymitosene and synthesis of its analog via a key PtCl2-catalyzed cycloisomerization.

Authors:  Lianzhu Liu; Yanzhao Wang; Liming Zhang
Journal:  Org Lett       Date:  2012-07-05       Impact factor: 6.005

2.  In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines.

Authors:  A Ghiorghis; A Talebian; R Clarke
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Internal azomethine ylide cycloaddition methodology for access to the substitution pattern of aziridinomitosene A.

Authors:  Drew R Bobeck; Don L Warner; Edwin Vedejs
Journal:  J Org Chem       Date:  2007-10-02       Impact factor: 4.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.